Diagnostic strategies and algorithms for investigating cancer predisposition syndromes in children presenting with malignancy

L Rossini, C Durante, S Bresolin, E Opocher… - Cancers, 2022 - mdpi.com
Simple Summary Here we provide an overview of several genetically determined conditions
that predispose to the development of solid and hematologic malignancies in children …

Comprehensive analysis of cyclin family gene expression in colon cancer

J Li, L Zhou, Y Liu, L Yang, D Jiang, K Li, S Xie… - Frontiers in …, 2021 - frontiersin.org
Colon cancer is a common malignancy of the digestive tract with high morbidity and
mortality. There is an urgent need to identify effective biomarkers for the early diagnosis of …

Clinically significant germline pathogenic variants are missed by tumor genomic sequencing

LA Stout, C Hunter, C Schroeder, N Kassem… - NPJ Genomic …, 2023 - nature.com
A germline pathogenic variant may be present even if the results of tumor genomic
sequencing do not suggest one. There are key differences in the assay design and reporting …

Full-length transcriptome analysis of Coptis deltoidea and identification of putative genes involved in benzylisoquinoline alkaloids biosynthesis based on combined …

F Zhong, L Huang, L Qi, Y Ma, Z Yan - Plant molecular biology, 2020 - Springer
Key message The study carry out comprehensive transcriptome analysis of C. deltoidea and
exploration of BIAs biosynthesis and accumulation based on UHPLC-MS/MS and combined …

[HTML][HTML] Patient-derived in vitro models for drug discovery in colorectal carcinoma

GM Ramzy, T Koessler, E Ducrey, T McKee, F Ris… - Cancers, 2020 - mdpi.com
Lack of relevant preclinical models that reliably recapitulate the complexity and
heterogeneity of human cancer has slowed down the development and approval of new anti …

[HTML][HTML] Next generation sequencing: from research area to clinical practice

C Di Resta, M Ferrari - Ejifcc, 2018 - ncbi.nlm.nih.gov
Translating the power of high-throughput sequencing technologies from research area into
clinical medicine is one of the major goal for several researchers and health-care providers …

Genetic polymorphisms and lung cancer risk: Evidence from meta-analyses and genome-wide association studies

C Liu, H Cui, D Gu, M Zhang, Y Fang, S Chen, M Tang… - Lung Cancer, 2017 - Elsevier
A growing number of studies investigating the association between Single Nucleotide
Polymorphisms (SNPs) and lung cancer risk have been published since over a decade ago …

Prognostic biomarkers and therapeutic targets in oral squamous cell carcinoma: a study based on cross-database analysis

W Yang, W Zhou, X Zhao, X Wang, L Duan, Y Li, L Niu… - Hereditas, 2021 - Springer
Background Oral squamous cell carcinoma (OSCC) is a malignant cancer, the survival rate
of patients is disappointing. Therefore, it is necessary to identify the driven-genes and …

Mechanisms of primary resistance to EGFR targeted therapy in advanced lung adenocarcinomas

Y Jin, X Shi, J Zhao, Q He, M Chen, J Yan, Q Ou, X Wu… - Lung Cancer, 2018 - Elsevier
Introduction Increasing evidence leads to a ratiocination that genetic heterogeneity of the
lung adenocarcinoma with EGFR mutations may impact clinical responses and outcomes to …

Integrated bioinformatics analysis of key genes involved in progress of colon cancer

H Yang, J Wu, J Zhang, Z Yang, W Jin… - Molecular genetics & …, 2019 - Wiley Online Library
Background Colon cancer is one of most malignant cancers around worldwide. Nearly 20%
patients were diagnosed at colon cancer with metastasis. However, the lack of …